CSL Behring Scoops Up This U.S. Biotech for $416 Million Post author:Sam Post published:August 27, 2017 Post category:BioPharma August 28, 2017By Mark Terry, BioSpace.com Breaking News StaffMelbourne, Australia… Source: BioSpace You Might Also Like Former Schering-Plough CEO Says This is the 'Worst Solution' to the Drug Pricing Dilemma August 24, 2017 Two-Year Old Biotech NousCom Nabs $49M to Fund New Drug Into Clinic November 5, 2017 GlaxoSmithKline CEO Kills 30+ Pre-Clinical and Clinical Programs July 25, 2017
Former Schering-Plough CEO Says This is the 'Worst Solution' to the Drug Pricing Dilemma August 24, 2017
